Related Experiment Video
Updated: Oct 12, 2025

12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.2K
Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge
Xuan Xu1, Qing-Ye Zhang1, Xin-Yi Chu1
1Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China.
Viruses
|November 27, 2021
Summary
Discovering new antiviral drugs is crucial. This study proposes a novel strategy targeting host molecules, leveraging genetic and evolutionary insights to identify promising antiviral drug targets and therapies.
Area of Science:
- Virology
- Genetics
- Drug Discovery
Background:
- Viral infections pose a significant global health challenge, with existing antiviral drugs often facing issues like drug resistance and narrow spectrums due to rapid viral mutation rates.
- Targeting host molecules represents a promising alternative strategy for antiviral drug development, mitigating resistance issues associated with targeting viral proteins.
- Advances in high-throughput sequencing and genetic studies (e.g., genome-wide association studies, CRISPR screening) provide valuable resources for identifying host-based drug targets.
Purpose of the Study:
- To propose a novel host-targeted antiviral drug discovery strategy integrating genetic and evolutionary principles.
- To identify and characterize the genetic, subcellular location, and evolutionary features of successful human antiviral targets.
- To utilize these features for screening novel druggable host targets and discovering potential antiviral drugs.
Main Methods:
- Comprehensive analysis of genetic, subcellular localization, and evolutionary characteristics of known human antiviral targets.
- Application of identified features to screen for novel, druggable host genes as potential antiviral targets.
- Utilizing screening results to identify potential antiviral drug candidates.
Main Results:
- Characterization of key genetic and evolutionary features associated with successful host-targeted antiviral therapies.
- Identification of novel druggable host targets with potential for broad-spectrum antiviral activity.
- Facilitation of the discovery pipeline for new antiviral medications.
Conclusions:
- A host-targeted drug discovery approach, informed by genetics and evolution, offers a robust strategy to overcome limitations of traditional antiviral therapies.
- Understanding the features of successful host targets is critical for efficient identification of new antiviral drug candidates.
- This strategy holds significant potential for accelerating the development of next-generation antiviral drugs.
Related Concept Videos
Viral Mutations
34.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
34.7K
Drug Discovery: Overview
9.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.4K
Retrovirus Life Cycles
47.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.6K
Retroviruses
12.8K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.8K
Evolutionary Relationships through Genome Comparisons
6.4K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
6.4K

